Sensitivity to vecuronium in seropositive and seronegative patients with myasthenia gravis

Anesthesia and Analgesia

Volumn 95, Issue 1, 2002, Pages 109-113

  Itoh, Hironori ^a   Shibata, Keizo ^a   Nitta, Shunichi ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROMUSCULAR BLOCKING AGENT; NITROUS OXIDE; OXYGEN; SEVOFLURANE; VECURONIUM;

ADULT; AGED; ARTICLE; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SENSITIVITY; FEMALE; FINGER; HUMAN; HUMAN TISSUE; INHALATION ANESTHESIA; MALE; MUSCLE TWITCH; MYASTHENIA GRAVIS; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR TRANSMISSION; PRIORITY JOURNAL; SERODIAGNOSIS; SUPERSENSITIVITY;

EID: 0036289712     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200207000-00019     Document Type: Article

References (28)

1. Seronegative myasthenia gravis: Evidence for plasma factor(s) interfering with acetylcholine receptor function
2. Seronegative myasthenia gravis
3. Electrophysiological characteristics in seronegative myasthenia gravis
4. Myasthenia gravis without acetylcholine-receptor antibody: A distinct disease entity
5. Sensitivity to both vecuronium and neostigmine in a sero-negative myasthenic patient
6. Neuromuscular effects of vecuronium in patients with seronegative myasthenia gravis
7. Antibody to acetylcholine receptor in myasthenia gravis: Prevalence, clinical correlates, and diagnostic value
8. Detection of antiacetylcholine receptor factors in serum and thymus from patients with myasthenia gravis
9. An alternate method for estimating the dose-response relationships of neuromuscular blocking drugs
10. Studies in myasthenia gravis: Review of a twenty-year experience in over 1200 patients
11. The relation between tetanic fade and receptor occlusion in the presence of competitive neuromuscular block
12. Atracurium in myasthenics undergoing thymectomy
13. Vecuronium dose-response and maintenance requirements in patients with myasthenia gravis
14. Neuromuscular response to succinylcholine-vecuronium sequence in three myasthenic patients undergoing thymectomy
15. Marked sensitivity to pancuronium in a patient without clinical manifestations of myasthenia gravis
16. Preanesthetic train-of-four fade predicts the atracurium requirement of myasthenia gravis patients
17. Myasthenia gravis
18. Myasthenia gravis: Long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity
19. Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis
20. Binding and blocking antibodies to the human acetylcholine receptor: Are they selected in various myasthenia gravis forms?
21. Diaphragmatic myasthenia in mother and child
22. Plasmapheresis in myasthenia gravis: A survey
23. Treatment of myasthenia gravis by immunoadsorption of plasma
24. The effects of diethyl ether, enflurane, and isoflurane at the neuromuscular junction
25. The neuromuscular blocking effects of vecuronium during sevoflurane, halothane and balanced anaesthesia in children
26. Reversal of rapacuronium block during propofol versus sevoflurane anesthesia
27. Augmentation of vecuronium-induced neuromuscular block during sevoflurane anaesthesia: Comparison with balanced anaesthesia using propofol or midazolam
28. Comparison between sevoflurane and propofol neuromuscular effects in a patient with myasthenia gravis: Effective doses of vecuronium